1
Spanholtz Jan: Methods and means for stem cell proliferation and subsequent generation and expansion of progenitor cells, as well as production of effector cells as clinical therapeutics.. Ipd Therapeutics, Spanholtz Jan, VAN LOON C J J, April 5, 2007: WO/2007/037682 (4 worldwide citation)

The invention provides means and methods for stem cell proliferation and subsequent generation and expansion of progenitor cells. The invention in particular provides media and other culture conditions for the same. The cells are preferably used as effector cells as clinical therapeutics.


2
Spanholtz Jan: Methods and means for stem cell proliferation and subsequent generation and expansion of progenitor cells, as well as production of effector cells as clinical therapeutics. Ipd Therapeutics, Spanholtz Jan, HATZMANN MJ, October 2, 2008: WO/2008/118020 (4 worldwide citation)

The invention is related to methods for expanding and differentiating hemopoietic progenitor cells in a medium comprising a collection of cytokines, desulphated glycosaminoglycan and human serum. The invention further relates to a collection of cells obtainable by a method of the invention, use of t ...


3
Jan Spanholtz: Methods and means for stem cell proliferation and subsequent generation and expansion of progenitor cells, as well as production of effector cells as clinical therapeutics. IPD THERAPEUTICS, Hoffmann & Baron, August 18, 2015: US09109202

The invention provides means and methods for stem cell proliferation and subsequent generation and expansion of progenitor cells. The invention in particular provides media and other culture conditions for the same. The cells are preferably used as effector cells as clinical therapeutics.


4
Wu Jingbo: Anti-tumor biologically active substance and preparation technology thereof. Affiliated Hospital Of Luzhou Medical College, weichang wei, April 30, 2008: CN200710050378

The invention discloses an antineoplastic biological active substance, which can culture heart tissue to antineoplastic cardiocytes culture fluid. The concrete steps are that cell suspension is made, alternate freezing and thawing is processed and centrifugal is filtered. The invention proves that t ...


5
Zhang Wei, Jin Guohua, Xu Xiaole: Compound fleece-flower root extract capsule and preparation method and usage thereof. Nantong University, Ge Lei, March 17, 2010: CN200910233002

The invention discloses a compound fleece-flower root extract capsule and a preparation method and usage thereof. The capsule is made from fleece-flower root, grassleaved sweetflag, indianmulberry, ganoderma lucidum, anemarrhena and leech. Studies of experimental pharmacology and clinical therapeuti ...


6

7
Jan Spanholtz: Methods and means for stem cell proliferation and subsequent generation and expansion of progenitor cells, as well as production of effector cells as clinical therapeutics. Hoffmann & Baron, January 15, 2009: US20090017539-A1

The invention provides means and methods for stem cell proliferation and subsequent generation and expansion of progenitor cells. The invention in particular provides media and other culture conditions for the same. The cells are preferably used as effector cells as clinical therapeutics.


8
Jan Spanholtz: Methods and means for stem cell proliferation and subsequent generation and expansion of progenitor cells, as well as production of effector cells as clinical therapeutics. Hoffmann & Baron, July 15, 2010: US20100178275-A1

The invention is related to methods for expanding and differentiating hemopoietic progenitor cells in a medium comprising a collection of cytokines, desulphated glycosaminoglycan and human serum. The invention further relates to a collection of cells obtainable by a method of the invention, use of t ...


9

10
Hu Chuanmin, Huang Hongtao, Wang Jian, Yi Weijing, Li Peng, Gao Lihong: Macrophagocyte transfer inhibition factor monoclonal antibody and method for making same. Hu Chuanmin, September 26, 2007: CN200610070899

The invention discloses a preparing method of monoclonal antibody (hMIF) to against human macrophage transferring inhibitor and getting method of amino acid sequence in biological medicine engineering technical domain, which comprises the following steps: augmenting out of hMIF gene from human breas ...



Click the thumbnails below to visualize the patent trend.